These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25624414)

  • 1. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.
    Špolcová A; Mikulášková B; Holubová M; Nagelová V; Pirnik Z; Zemenová J; Haluzík M; Železná B; Galas MC; Maletínská L
    J Alzheimers Dis; 2015; 45(3):823-35. PubMed ID: 25624414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
    Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
    Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.
    Ma DL; Chen FQ; Xu WJ; Yue WZ; Yuan G; Yang Y
    J Neurochem; 2015 Oct; 135(2):301-8. PubMed ID: 26183127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidized Prolactin-Releasing Peptide Agonist Attenuates Hypothermia-Induced Tau Hyperphosphorylation in Neurons.
    Pražienková V; Schirmer C; Holubová M; Železná B; Kuneš J; Galas MC; Maletínská L
    J Alzheimers Dis; 2019; 67(4):1187-1200. PubMed ID: 30689580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidized analogues of the anorexigenic CART (cocaine- and amphetamine-regulated transcript) neuropeptide show anorexigenic and neuroprotective potential in mouse model of monosodium-glutamate induced obesity.
    Charvát V; Strnadová A; Myšková A; Sýkora D; Blechová M; Železná B; Kuneš J; Maletínská L; Pačesová A
    Eur J Pharmacol; 2024 Oct; 980():176864. PubMed ID: 39084452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
    Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
    J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes.
    Yang Y; Zhang J; Ma D; Zhang M; Hu S; Shao S; Gong CX
    J Alzheimers Dis; 2013; 37(3):637-48. PubMed ID: 23948890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
    Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
    J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice.
    Xiong H; Zheng C; Wang J; Song J; Zhao G; Shen H; Deng Y
    J Alzheimers Dis; 2013; 37(3):623-35. PubMed ID: 24008687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats.
    Špolcová A; Mikulášková B; Kršková K; Gajdošechová L; Zórad Š; Olszanecki R; Suski M; Bujak-Giżycka B; Železná B; Maletínská L
    BMC Neurosci; 2014 Sep; 15():111. PubMed ID: 25257559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
    Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L
    Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
    Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y
    PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.
    Mráziková L; Hojná S; Pačesová A; Hrubá L; Strnadová V; Neprašová B; Železná B; Kuneš J; Maletínská L
    Nutr Diabetes; 2022 May; 12(1):26. PubMed ID: 35589696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
    Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical tau burden and behavioural dysfunctions in mice exposed to monosodium glutamate in early life.
    Hassaan PS; Dief AE; Zeitoun TM; Baraka AM; Deacon RMJ; Elshorbagy A
    PLoS One; 2019; 14(8):e0220720. PubMed ID: 31412065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance.
    Mráziková L; Hojná S; Vaculová P; Strnad Š; Vrkoslav V; Pelantová H; Kuzma M; Železná B; Kuneš J; Maletínská L
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
    Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
    Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62.
    Jung HJ; Kim YJ; Eggert S; Chung KC; Choi KS; Park SA
    Exp Neurol; 2013 Oct; 248():441-50. PubMed ID: 23906983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease.
    Gratuze M; El Khoury NB; Turgeon A; Julien C; Marcouiller F; Morin F; Whittington RA; Marette A; Calon F; Planel E
    Neurobiol Dis; 2017 Feb; 98():1-8. PubMed ID: 27793638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.